PF-3450074

N/A

Report date: 2024/11/18 15:23:34

NME

Base Information

Drug NamePF-3450074

Drug Alias NamePF-3450074

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionReverse transcriptase inhibitors

TargetsReverse transcriptase

Therapy Area/IndicationsHIV Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesPfizer Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesPfizer Inc

Active IndicationsN/A

Inactive IndicationsHIV Infections

ATC CodeN/A